Interim Analysis of the START Study – Extensive Electrocardiographic Monitoring Confirms the Good Cardiac Safety Profile of Fingolimod

Volker Limmroth, Wilhelm Haverkamp, Ralf Dechend, Michael Lang, Judith Haas, Bert Wagner, Stephan Richter, Heinke Schieb, Tjalf Ziemssen